Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124
Fujita, T.; Miyazaki, M.
Masui. Japanese Journal of Anesthesiology 21(5): 450-457
1972
ISSN/ISBN: 0021-4892 PMID: 4403862 Document Number: 52851
Document emailed within 1 workday
Related Documents
Singh, B.N. 1973: Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias New Zealand Medical Journal 78(504): 482-486Pitzalis, M.; Massari, F.; Totaro, P.; Mastropasqua, F.; Rizzon, P. 1992: Is it possible to predict the anti-arrhythmic effect of beta blockers based on various relations between premature ventricular beat and the preceding cardiac cycle? Cardiologia 37(12): 853-857
Lotto, A.; Finzi, A. 1986: Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification Giornale Italiano di Cardiologia 16(4): 333-335
Rodrigues, R.; Kornfeld, J.; Pereira, E.M. 1972: Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance Arquivos Brasileiros de Cardiologia 25(6): 471-475
Laubie, M.; Cheymol, G.; Mouillé, P.; Gilbert, J.C.; Schmitt, H. 1973: Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395) Archives Internationales de Pharmacodynamie et de Therapie 201(2): 323-333
Libersa, C.; Caron, J.; Guedon-Moreau, L.; Lacroix, D. 1992: Pro-arrhythmic effects of anti-arrhythmic agents. Study methods and difficulties in analysis Therapie 47(5): 363-365
Miyazaki, M.; Nioka, S.; Fujita, T. 1975: Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin) Masui. Japanese Journal of Anesthesiology 24(1): 56-63
Di Luzio, V.; Purcaro, A.; Curzi, G.; Di Segni, E.; Chiesa, R.; Di Giuseppe, F. 1972: Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity Bollettino Della Societa Italiana di Cardiologia 17(3): 179-187
Koebe, P.; Rost, R.; Reinke, A.; Nagel, N.; Merten, U. 1985: Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion Arzneimittel-Forschung 35(2): 522-529
Stoschitzky, K.; Lindner, W. 1990: Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol Wiener Medizinische Wochenschrift 140(6-7): 156-162
Chourashy, B.K. 1988: Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates Journal of the Indian Medical Association 86(10): 274-276
Urbaszek, W.; Modersohn, D. 1979: Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects Zeitschrift für Arztliche Fortbildung 73(3): 101-106
Ljubuncić, P.; Stojiljković, M.P.; Winterhalter-Jadrić, M.; Vidović, Z.; Mujić, F. 1992: Efficacy of pretreatment with adrenergic beta-receptor blockers in the prevention of cardiotoxic effects of isoprenaline in rats Vojnosanitetski Pregled 49(4): 297-304
Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Held, P.H.; Yusuf, S. 1993: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction European Heart Journal 14(Suppl): 18-25
Lecointre, C.; Aupois, R. 1977: The beta-blockers and anesthesia L' Information Dentaire 59(41): 39-44
Nozaki, A.; Sugimoto, T. 1985: Evaluation of anti-arrhythmic drug efficacy Nihon Rinsho. Japanese Journal of Clinical Medicine 43(11): 2411-2416
Maslov, L.N.; Krylatov, A.V.; Lishmanov, I.B. 1997: The anti-arrhythmic effect of the selective sigma-receptor antagonist DuP 734 [1-(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'-oxoethyl)piper idine HBr Eksperimental'naia i Klinicheskaia Farmakologiia 60(2): 24-26
Haverkamp, W.; Wichter, T.; Chen, X.; Hördt, M.; Willems, S.; Rotman, B.; Hindricks, G.; Kottkamp, H.; Borggrefe, M.; Breithardt, G. 1994: The pro-arrhythmic effects of anti-arrhythmia agents Zeitschrift für Kardiologie 83(Suppl 5): 75-85